EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment

Will Lawn iD, Katie Trinci, Claire Mokrysz iD, Anna Borissova, Shelan Ofori, Kat Petrilli iD, Michael Bloomfield, Zarah R Haniff, Daniel Hall, Natalia Fernandez-Vinson, Simiao Wang, Amir Englund und 4 weitere

Addiction · 2023

DOI: 10.1111/add.16154 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Addiction, 2023. Verfasst von Will Lawn und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK. Hauptthemen laut MEDLINE: Cannabis, Cannabidiol, Marijuana Smoking, Hallucinogens. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Long‐term harms of cannabis may be exacerbated in adolescence, but little is known about the acute effects of cannabis in adolescents. We aimed to (i) compare the acute effects of cannabis in adolescent and adult cannabis users and (ii) determine if cannabidiol (CBD) acutely modulates the effects of delta‐9‐tetrahydocannabinol (THC).

Design

Randomised, double‐blind, placebo‐controlled, crossover experiment. The experiment was registered on ClinicalTrials.gov (NCT04851392).

Setting

Laboratory in London, United Kingdom.

Participants

Twenty‐four adolescents (12 women, 16‐ to 17‐year‐olds) and 24 adults (12 women, 26‐ to 29‐year‐olds) who used cannabis 0.5–3 days/week and were matched on cannabis use frequency (mean = 1.5 days/week).

Intervention

We administered three weight‐adjusted vaporised cannabis flower preparations: ‘THC’ (8 mg THC for 75 kg person); ‘THC + CBD’ (8 mg THC and 24 mg CBD for 75 kg person); and ‘PLA’ (matched placebo).

Measurements

Primary outcomes were (i) subjective ‘feel drug effect’; (ii) verbal episodic memory (delayed prose recall); and (iii) psychotomimetic effect (Psychotomimetic States Inventory).

Findings

Compared with ‘PLA’, ‘THC’ and ‘THC + CBD’ significantly ( P < 0.001) increased ‘feel drug effect’ (mean difference [MD] = 6.3, 95% CI = 5.3–7.2; MD = 6.8, 95% CI = 6.0–7.7), impaired verbal episodic memory (MD = –2.7, 95% CI = −4.1 to −1.4; MD = −2.9, 95% CI = −4.1 to −1.7) and increased psychotomimetic effects (MD = 7.8, 95% CI = 2.8–12.7; MD = 10.8, 95% CI = 6.2–15.4). There was no evidence that adolescents differed from adults in their responses to cannabis (interaction P ≥ 0.4). Bayesian analyses supported equivalent effects of cannabis in adolescents and adults (Bayes factor [BF 01 ] >3). There was no evidence that CBD significantly modulated the acute effects of THC.

Conclusions

Adolescent cannabis users are neither more resilient nor more vulnerable than adult cannabis users to the acute psychotomimetic, verbal memory‐impairing or subjective effects of cannabis. Furthermore, in adolescents and adults, vaporised cannabidiol does not mitigate the acute harms caused by delta‐9‐tetrahydocannabinol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabisCannabidiolMarijuana SmokingHallucinogensAdultAdolescentHumansFemaleBayes TheoremDronabinolCannabinoid Receptor AgonistsDouble-Blind MethodCross-Over Studies

Stichwörter der Autor:innen

CBDTHCadolescencecannabiscognitionmemorypsychosissubjective drug effects

Substanzen

CannabidiolDronabinolHallucinogensCannabinoid Receptor Agonists

Autor:innen und Institutionen

  • Department of Psychology, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK.
  • Department of Addictions, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK.
  • Clinical Psychopharmacology Unit, Clinical Educational and Health Psychology, University College London, London, UK.
  • Department of Neuroimaging, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK.
  • NIHR University College London Hospitals Biomedical Research Centre, University College Hospital, London, UK.
  • Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.

ORCID-Profile: Will Lawn, Claire Mokrysz, Kat Petrilli, Tom P Freeman

Förderung

  • Medical Research Council

Zitieren

APA

Lawn, W., Trinci, K., Mokrysz, C., Borissova, A., Ofori, S., Petrilli, K., Bloomfield, M., Haniff, Z. R., Hall, D., Fernandez-Vinson, N., Wang, S., Englund, A., Chesney, E., Wall, M. B., Freeman, T. P., & Curran, H. V. (2023). The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment. Addiction. https://doi.org/10.1111/add.16154

Vancouver

Lawn W, Trinci K, Mokrysz C, Borissova A, Ofori S, Petrilli K, et al. The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment. Addiction. 2023. doi:10.1111/add.16154

BibTeX
@article{Lawn2023,
  author = {Lawn, Will and Trinci, Katie and Mokrysz, Claire and Borissova, Anna and Ofori, Shelan and Petrilli, Kat and Bloomfield, Michael and Haniff, Zarah R and Hall, Daniel and Fernandez-Vinson, Natalia and Wang, Simiao and Englund, Amir and Chesney, Edward and Wall, Matthew B and Freeman, Tom P and Curran, H Valerie},
  title = {The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment},
  journal = {Addiction},
  year = {2023},
  doi = {10.1111/add.16154}
}
Kostenlos starten →